(-)-epigallocatechin 3-gallate multiple interactions ISO RGD:733798 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CBLB mRNA CTD PMID:22079256 (-)-epigallocatechin 3-gallate increases expression ISO RGD:733798 6480464 epigallocatechin gallate results in increased expression of CBLB mRNA CTD PMID:22079256 17beta-estradiol multiple interactions ISO RGD:733798 6480464 EGF protein inhibits the reaction [Estradiol results in decreased expression of CBLB mRNA] CTD PMID:24758408 17beta-estradiol decreases expression ISO RGD:733798 6480464 Estradiol results in decreased expression of CBLB mRNA CTD PMID:24758408 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CBLB mRNA CTD PMID:22298810 , PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733799 6480464 Tetrachlorodibenzodioxin affects the expression of CBLB mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CBLB mRNA CTD PMID:21215274 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CBLB mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of CBLB mRNA CTD PMID:21346803 2-hydroxypropanoic acid increases expression ISO RGD:733798 6480464 Lactic Acid results in increased expression of CBLB mRNA CTD PMID:30851411 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of CBLB mRNA CTD PMID:21346803 4-hydroxynon-2-enal decreases expression ISO RGD:733798 6480464 4-hydroxy-2-nonenal results in decreased expression of CBLB mRNA CTD PMID:12419474 4-hydroxyphenyl retinamide decreases expression ISO RGD:733799 6480464 Fenretinide results in decreased expression of CBLB mRNA CTD PMID:28973697 acrolein multiple interactions ISO RGD:733798 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CBLB mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CBLB mRNA CTD PMID:32699268 aflatoxin B1 affects expression ISO RGD:733798 6480464 Aflatoxin B1 affects the expression of CBLB protein CTD PMID:20106945 aflatoxin B1 decreases methylation ISO RGD:733798 6480464 Aflatoxin B1 results in decreased methylation of CBLB gene, Aflatoxin B1 results in decreased methylation of CBLB intron CTD PMID:27153756 , PMID:30157460 alpha-pinene multiple interactions ISO RGD:733798 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CBLB mRNA, [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in increased expression of CBLB mRNA CTD PMID:32699268 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CBLB mRNA CTD PMID:16483693 aristolochic acid A decreases expression ISO RGD:733798 6480464 aristolochic acid I results in decreased expression of CBLB mRNA CTD PMID:33212167 arsenite(3-) decreases expression ISO RGD:733799 6480464 arsenite results in decreased expression of CBLB mRNA CTD PMID:18191166 arsenite(3-) multiple interactions ISO RGD:733798 6480464 arsenite inhibits the reaction [G3BP1 protein binds to CBLB mRNA] CTD PMID:32406909 azoxystrobin decreases expression ISO RGD:733798 6480464 azoxystrobin results in decreased expression of CBLB mRNA CTD PMID:33512557 benzene increases expression ISO RGD:733798 6480464 Benzene results in increased expression of CBLB mRNA CTD PMID:19162166 benzo[a]pyrene decreases expression ISO RGD:733798 6480464 Benzo(a)pyrene results in decreased expression of CBLB mRNA CTD PMID:20064835 benzo[a]pyrene increases methylation ISO RGD:733799 6480464 Benzo(a)pyrene results in increased methylation of CBLB intron CTD PMID:27901495 benzo[a]pyrene decreases methylation ISO RGD:733798 6480464 Benzo(a)pyrene results in decreased methylation of CBLB promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:733799 6480464 Benzo(a)pyrene results in increased expression of CBLB mRNA CTD PMID:22228805 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:733798 6480464 7 more ... CTD PMID:19150397 bis(2-ethylhexyl) phthalate increases expression ISO RGD:733799 6480464 Diethylhexyl Phthalate results in increased expression of CBLB mRNA CTD PMID:21318169 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CBLB mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:733799 6480464 bisphenol A results in increased expression of CBLB mRNA CTD PMID:35598803 bisphenol A decreases methylation ISO RGD:733798 6480464 bisphenol A results in decreased methylation of CBLB gene CTD PMID:31601247 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of CBLB gene CTD PMID:28505145 butanal decreases expression ISO RGD:733798 6480464 butyraldehyde results in decreased expression of CBLB mRNA CTD PMID:26079696 caffeine increases phosphorylation ISO RGD:733798 6480464 Caffeine results in increased phosphorylation of CBLB protein CTD PMID:35688186 calcitriol decreases expression ISO RGD:733798 6480464 Calcitriol results in decreased expression of CBLB mRNA CTD PMID:16002434 cobalt dichloride increases expression ISO RGD:733798 6480464 cobaltous chloride results in increased expression of CBLB mRNA CTD PMID:19376846 copper atom multiple interactions ISO RGD:733798 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CBLB mRNA, [NSC 689534 binds to Copper] which results in increased expression of CBLB mRNA CTD PMID:20971185 , PMID:30911355 copper(0) multiple interactions ISO RGD:733798 6480464 [Chelating Agents binds to Copper] which results in decreased expression of CBLB mRNA, [NSC 689534 binds to Copper] which results in increased expression of CBLB mRNA CTD PMID:20971185 , PMID:30911355 copper(II) sulfate increases expression ISO RGD:733798 6480464 Copper Sulfate results in increased expression of CBLB mRNA CTD PMID:19549813 coumestrol decreases expression ISO RGD:733798 6480464 Coumestrol results in decreased expression of CBLB mRNA CTD PMID:19167446 coumestrol multiple interactions ISO RGD:733798 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA CTD PMID:19167446 crocidolite asbestos decreases expression ISO RGD:733798 6480464 Asbestos, Crocidolite results in decreased expression of CBLB mRNA CTD PMID:29523930 cyclosporin A increases expression ISO RGD:733798 6480464 Cyclosporine results in increased expression of CBLB mRNA CTD PMID:20106945 , PMID:25562108 D-gluconic acid decreases expression EXP 6480464 gluconic acid results in decreased expression of CBLB mRNA CTD PMID:16556975 deguelin decreases expression ISO RGD:733798 6480464 deguelin results in decreased expression of CBLB mRNA CTD PMID:33512557 dexamethasone increases expression ISO RGD:733799 6480464 Dexamethasone results in increased expression of CBLB, Dexamethasone results in increased expression of CBLB mRNA CTD PMID:22733784 dichloromethane increases expression EXP 6480464 Methylene Chloride results in increased expression of CBLB mRNA CTD PMID:20955722 diuron increases expression EXP 6480464 Diuron results in increased expression of CBLB mRNA CTD PMID:21551480 dorsomorphin multiple interactions ISO RGD:733798 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO RGD:733799 6480464 Doxorubicin results in increased expression of CBLB mRNA CTD PMID:25896364 doxorubicin decreases expression ISO RGD:733798 6480464 Doxorubicin results in decreased expression of CBLB mRNA CTD PMID:29803840 elemental selenium decreases expression ISO RGD:733798 6480464 Selenium results in decreased expression of CBLB mRNA CTD PMID:19244175 Enterolactone multiple interactions ISO RGD:733798 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of CBLB mRNA CTD PMID:19167446 ethylbenzene increases expression EXP 6480464 ethylbenzene results in increased expression of CBLB mRNA CTD PMID:20955722 fenofibrate increases expression ISO RGD:733799 6480464 Fenofibrate results in increased expression of CBLB mRNA CTD PMID:21318169 fenofibrate multiple interactions ISO RGD:733799 6480464 PPARA protein affects the reaction [Fenofibrate results in increased expression of CBLB mRNA] CTD PMID:21318169 folic acid decreases expression ISO RGD:733799 6480464 Folic Acid results in decreased expression of CBLB mRNA CTD PMID:25629700 folpet increases expression ISO RGD:733799 6480464 folpet results in increased expression of CBLB mRNA CTD PMID:31558096 formaldehyde decreases expression ISO RGD:733798 6480464 Formaldehyde results in decreased expression of CBLB mRNA CTD PMID:17938736 , PMID:20655997 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CBLB mRNA CTD PMID:22061828 hydrogen peroxide affects expression ISO RGD:733798 6480464 Hydrogen Peroxide affects the expression of CBLB mRNA CTD PMID:20044591 hydrogen peroxide decreases expression ISO RGD:733798 6480464 Hydrogen Peroxide results in decreased expression of CBLB mRNA CTD PMID:18951874 isoprenaline increases expression ISO RGD:733799 6480464 Isoproterenol results in increased expression of CBLB mRNA CTD PMID:20003209 lead diacetate decreases expression ISO RGD:733799 6480464 lead acetate results in decreased expression of CBLB mRNA CTD PMID:21829687 lead(0) affects expression ISO RGD:733798 6480464 Lead affects the expression of CBLB mRNA CTD PMID:28903495 lead(0) affects splicing ISO RGD:733798 6480464 Lead affects the splicing of CBLB mRNA CTD PMID:28903495 lead(2+) affects expression ISO RGD:733798 6480464 Lead affects the expression of CBLB mRNA CTD PMID:28903495 lead(2+) affects splicing ISO RGD:733798 6480464 Lead affects the splicing of CBLB mRNA CTD PMID:28903495 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CBLB mRNA CTD PMID:30467583 methidathion decreases expression ISO RGD:733799 6480464 methidathion results in decreased expression of CBLB mRNA CTD PMID:34813904 methotrexate decreases expression ISO RGD:733798 6480464 Methotrexate results in decreased expression of CBLB mRNA CTD PMID:24449571 N-methyl-4-phenylpyridinium increases expression ISO RGD:733799 6480464 1-Methyl-4-phenylpyridinium results in increased expression of CBLB mRNA CTD PMID:17475336 nickel atom increases expression ISO RGD:733798 6480464 Nickel results in increased expression of CBLB mRNA CTD PMID:25583101 nickel sulfate increases expression ISO RGD:733798 6480464 nickel sulfate results in increased expression of CBLB mRNA CTD PMID:22714537 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CBLB mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:733798 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in increased expression of CBLB mRNA more ... CTD PMID:32699268 p-menthan-3-ol decreases expression ISO RGD:733798 6480464 Menthol results in decreased expression of CBLB mRNA CTD PMID:26760959 paracetamol increases expression ISO RGD:733798 6480464 Acetaminophen results in increased expression of CBLB mRNA CTD PMID:26690555 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CBLB mRNA CTD PMID:33387578 paracetamol affects expression ISO RGD:733798 6480464 Acetaminophen affects the expression of CBLB mRNA CTD PMID:25458485 pentanal decreases expression ISO RGD:733798 6480464 pentanal results in decreased expression of CBLB mRNA CTD PMID:26079696 perfluorohexanesulfonic acid decreases expression ISO RGD:733798 6480464 perfluorohexanesulfonic acid results in decreased expression of CBLB mRNA CTD PMID:25812627 perfluorononanoic acid decreases expression ISO RGD:733798 6480464 perfluoro-n-nonanoic acid results in decreased expression of CBLB mRNA CTD PMID:25812627 perfluorononanoic acid increases expression ISO RGD:733798 6480464 perfluoro-n-nonanoic acid results in increased expression of CBLB mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:733798 6480464 perfluorooctane sulfonic acid results in decreased expression of CBLB mRNA CTD PMID:25812627 perfluorooctanoic acid decreases expression ISO RGD:733798 6480464 perfluorooctanoic acid results in decreased expression of CBLB mRNA CTD PMID:25812627 phenobarbital affects expression ISO RGD:733799 6480464 Phenobarbital affects the expression of CBLB mRNA CTD PMID:23091169 picoxystrobin decreases expression ISO RGD:733798 6480464 picoxystrobin results in decreased expression of CBLB mRNA CTD PMID:33512557 pirinixic acid multiple interactions ISO RGD:733799 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of CBLB mRNA, PPARA protein affects the reaction [pirinixic acid results in increased expression of CBLB mRNA] CTD PMID:19710929 , PMID:21318169 pirinixic acid increases expression ISO RGD:733799 6480464 pirinixic acid results in increased expression of CBLB mRNA CTD PMID:18301758 , PMID:21318169 pirinixic acid multiple interactions ISO RGD:733798 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CBLB mRNA CTD PMID:19710929 potassium chromate multiple interactions ISO RGD:733798 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CBLB mRNA CTD PMID:22079256 potassium chromate decreases expression ISO RGD:733798 6480464 potassium chromate(VI) results in decreased expression of CBLB mRNA CTD PMID:22079256 potassium dichromate decreases expression ISO RGD:733799 6480464 Potassium Dichromate results in decreased expression of CBLB mRNA CTD PMID:23608068 pyrimidifen decreases expression ISO RGD:733798 6480464 pyrimidifen results in decreased expression of CBLB mRNA CTD PMID:33512557 rac-lactic acid increases expression ISO RGD:733798 6480464 Lactic Acid results in increased expression of CBLB mRNA CTD PMID:30851411 rotenone increases expression EXP 6480464 Rotenone results in increased expression of CBLB mRNA CTD PMID:28374803 SB 431542 multiple interactions ISO RGD:733798 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom decreases expression ISO RGD:733798 6480464 Selenium results in decreased expression of CBLB mRNA CTD PMID:19244175 silver atom decreases expression ISO RGD:733799 6480464 Silver results in decreased expression of CBLB mRNA CTD PMID:27131904 silver(0) decreases expression ISO RGD:733799 6480464 Silver results in decreased expression of CBLB mRNA CTD PMID:27131904 sodium arsenite increases expression ISO RGD:733798 6480464 sodium arsenite results in increased expression of CBLB mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO RGD:733798 6480464 sodium arsenite results in decreased expression of CBLB mRNA CTD PMID:34032870 sodium dichromate increases expression ISO RGD:733799 6480464 sodium bichromate results in increased expression of CBLB mRNA CTD PMID:31558096 succimer multiple interactions ISO RGD:733799 6480464 [Succimer co-treated with Magnetite Nanoparticles] affects the expression of CBLB mRNA CTD PMID:26378955 sulforaphane increases expression ISO RGD:733798 6480464 sulforaphane results in increased expression of CBLB mRNA CTD PMID:31838189 sunitinib increases expression ISO RGD:733798 6480464 Sunitinib results in increased expression of CBLB mRNA CTD PMID:31533062 tamoxifen increases expression ISO RGD:733799 6480464 Tamoxifen results in increased expression of CBLB mRNA CTD PMID:25123088 tebufenpyrad decreases expression ISO RGD:733798 6480464 4-chloro-N-((4-(1, 1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in decreased expression of CBLB mRNA CTD PMID:33512557 titanium dioxide increases expression ISO RGD:733799 6480464 titanium dioxide results in increased expression of CBLB mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CBLB mRNA CTD PMID:25729387 topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CBLB mRNA CTD PMID:25729387 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CBLB mRNA CTD PMID:20955722 trichostatin A decreases expression ISO RGD:733798 6480464 trichostatin A results in decreased expression of CBLB mRNA CTD PMID:24935251 , PMID:26272509 trichostatin A multiple interactions ISO RGD:733798 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CBLB mRNA CTD PMID:27188386 urethane increases expression ISO RGD:733798 6480464 Urethane results in increased expression of CBLB mRNA CTD PMID:28818685 valproic acid affects expression ISO RGD:733798 6480464 Valproic Acid affects the expression of CBLB mRNA CTD PMID:25979313 valproic acid increases expression ISO RGD:733798 6480464 Valproic Acid results in increased expression of CBLB mRNA CTD PMID:24935251 valproic acid multiple interactions ISO RGD:733798 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CBLB mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:733798 6480464 Valproic Acid results in decreased expression of CBLB mRNA CTD PMID:23179753 more ... vitamin E decreases expression ISO RGD:733798 6480464 Vitamin E results in decreased expression of CBLB mRNA CTD PMID:19244175 vorinostat decreases expression ISO RGD:733798 6480464 vorinostat results in decreased expression of CBLB mRNA CTD PMID:27188386